EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies

Hyewon Seo iD, Sun-Ji Park iD, Minsoo Song

Cells · 04.03.2025 · 14 (5) · 376

DOI: 10.3390/cells14050376 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 04.03.2025. Verfasst von Hyewon Seo und 2 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Development Center, Daegu-Gyeongbukk Medical Innovation Foundation (K-MEDI hub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea. Hauptthemen laut MEDLINE: Diabetic Retinopathy. Die Arbeit wurde bisher 133-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Bio & Medical Technology Development Program of the National Research Foundation (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is one of the most prevalent complications of diabetes, affecting nearly one-third of patients with diabetes mellitus and remaining a leading cause of blindness worldwide. Among the various diabetes-induced complications, DR is of particular importance due to its direct impact on vision and the irreversible damage to the retina. DR is characterized by multiple pathological processes, primarily a hyperglycemia-induced inflammatory response and oxidative stress. Current gold standard therapies, such as anti-VEGF injections and photocoagulation, have shown efficacy in slowing disease progression. However, challenges such as drug resistance, partial therapeutic responses, and the reliance on direct eye injections—which often result in low patient compliance—remain unresolved. This review provides a comprehensive overview of the underlying molecular mechanisms in DR, the current therapies, and their unmet needs for DR treatment. Additionally, emerging therapeutic strategies for improving DR treatment outcomes are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyHumansAnimalsOxidative Stress

Stichwörter der Autor:innen

diabetic complicationsdiabetic retinopathyinflammationmolecular mechanismoxidative stresstherapeutics

Autor:innen und Institutionen

  • New Drug Development Center, Daegu-Gyeongbukk Medical Innovation Foundation (K-MEDI hub), 80 Cheombok-ro, Dong-gu, Daegu 41061, Republic of Korea.

ORCID-Profile: Hyewon Seo, Sun-Ji Park

Förderung

  • National Research Foundation of Korea
  • Bio & Medical Technology Development Program of the National Research Foundation (NRF)

Zitieren

APA

Seo, H., Park, S. J., & Song, M. (2025). Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies. Cells, 14(5), 376. https://doi.org/10.3390/cells14050376

Vancouver

Seo H, Park SJ, Song M. Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies. Cells. 2025;14(5):376. doi:10.3390/cells14050376

BibTeX
@article{Seo2025,
  author = {Seo, Hyewon and Park, Sun-Ji and Song, Minsoo},
  title = {Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {376},
  doi = {10.3390/cells14050376}
}
Kostenlos starten →